KCNH2 and Arrhythmia: Since the dominant action of class III antiarrhythmic agents is to lengthen the APD by a reduction of IKr, it is thought that the therapeutic effect of the agents against arrhythmia in the study subjects is manifested by offsetting oversupplied KCNH2 currents.